Company profile
The Cooper Companies, Inc.
NASDAQ: COO · Healthcare · Medical - Instruments & Supplies
#68 of 1,418 Healthcare companies by revenue49th-percentile growth
EA Score
86AFH 85DQ 95GM 65SS 97
v0.1 · 65/100 weight · provisional
↑ Piotroski F, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$4.2B
Rev growth YoY (TTM)
+6.1%
Net income (FY)
$374.9M
Employees
15,000
as of 2026-08-05
Market cap
$14.6B
as of 2026-08-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$4.1B$4.1B2025
Net income$374.9M$374.9M2025
Operating income$682.9M$682.9M2025
Total assets$12.4B$12.4B2025
Liabilities$4.2B$4.2B2025
Equity$8.2B$8.2B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Coopervision67%
Coopersurgical33%
By geography
UNITED STATES46%
Europe40%
Rest Of World, Excluding United States And Europe13%
The read
What is The Cooper Companies, Inc.’s revenue?
The Cooper Companies, Inc. booked $4.1B in FY2025 revenue, growing 5.1% year over year — about the middle of the pack among Healthcare companies we track, at a 9.2% net margin.
Peers · Healthcare
DexCom, Inc.87AIllumina, Inc.84B+IDEXX Laboratories, Inc.88AAlign Technology, Inc.83B+Mettler-Toledo International Inc.80B+Charles River Laboratories International, Inc.73BNeighbors
Contra Costa →Key facts
CEOAlbert G. White
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersSan Ramon, CA
ExchangeNASDAQ: COO
Employees15,000
IPO date1983-01-21
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.